ClinicalTrials.Veeva

Menu

Percutaneous Electrical Nerve Stimulation (PENS) of the Auricle for Post Operative Pain Solution(POPS) - Cardiac Surgery

D

DyAnsys

Status

Completed

Conditions

Midline Sternotomy Incision
Post Operative Pain

Treatments

Device: Primary Relief v 2.0

Study type

Interventional

Funder types

Industry

Identifiers

NCT03750357
PR2-POPS-18
CS/PRv2.0/01/2018 (Other Identifier)

Details and patient eligibility

About

Percutaneous Electrical Nerve Stimulation (PENS) of the auricle for acute pain management post cardiac surgery

Full description

A well formulated analgesic protocol is fundamental to fast tracking post cardiac surgery. Traditional analgesic methods have their own set of drawbacks unique to cardiac surgery. Opioids have well established side effects like nausea, vomiting, respiratory depression, urinary retention. Regional anesthetic techniques in anti coagulated patients may result in potentially catastrophic neurological, bleeding and thromboembolic sequelae. Non steroidal Anti Inflammatory Drugs (NSAIDs) have been associated with increased cerebrovascular events, renal dysfunction, sternal wound infections. These make alternative therapies, including non pharmacological modalities, attractive options for optimal analgesic therapy during the post operative period.

Alternative methods like topical application of COX -2 inhibitors, intravenous magnesium, Transcutaneous Electrical Nerve Stimulation (TENS) have been tried with varied results in cardiac surgery. A somatotopic relationship has been described between the auricle and the other anatomical regions of the body. When specific points are accurately identified along the meridians of the ear and stimulated electrically, analgesic effects are known to occur. Percutaneous Electrical Nerve Stimulation (PENS) of the auricle and its efficacy in management of post midline sternotomy pain has not been evaluated previously. Primary Relief v 2.0 is a device which provides continuous PENS aimed at non pharmacological post operative pain management.

Enrollment

60 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cardiac surgery patient with midline sternotomy incision

Exclusion criteria

  1. Thoracotomy incisions
  2. Patients with pacemakers,
  3. Post operative cognitive dysfunction
  4. Anticipated ventilation > 24 hrs
  5. Pre operative opioid therapy
  6. Ear infections
  7. Skin lesions / allergy to adhesive materials
  8. Re-exploration for any reason

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

60 participants in 2 patient groups

Primary Relief v 2.0 with Paracetamol
Experimental group
Description:
Group A will be treated with Primary Relief v 2.0(1 - 100Hz) sweep stimulation with increase in power of the stimulation for fixed interval of time.
Treatment:
Device: Primary Relief v 2.0
Only Paracetamol
No Intervention group
Description:
Group B will be treated with paracetamol drug.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems